Boston Scientific CORP Form 4 insider transactions
NYSE
David S. Wichmann, a director at Boston Scientific, acquired 2,901 shares of common stock as an annual equity award on May 9, 2024.
NYSE
Director John E. Sununu received an annual equity award of 2,901 shares of Boston Scientific common stock on May 9, 2024.
NYSE
Director Jessica L. Mega reported the acquisition of 2,901 shares of Boston Scientific common stock as an annual equity award and the disposal of 6,154 shares.
NYSE
Director Edward J. Ludwig reports acquisition of 2,901 shares of Boston Scientific common stock as part of an annual equity award.
NYSE
Director Susan E. Morano received equity awards in the form of restricted stock and deferred stock units from Boston Scientific on May 9, 2024.
NYSE
Director Yoshiaki Fujimori of Boston Scientific Corp. received an annual equity award of 2,901 shares of common stock on May 9, 2024.
NYSE
Director Charles J. Dockendorff received 2,901 shares of Boston Scientific Corp. stock as an annual equity award.
NYSE
Director Charles J. Dockendorff of Boston Scientific Corp. reports the sale of 3,946 shares of common stock at $72.70 per share under a pre-established Rule 10b5-1 trading plan.
NYSE
John Bradley Sorenson, EVP, Global Operations at Boston Scientific, reports the acquisition and disposal of common stock and restricted stock units on May 2, 2024.
NYSE
Arthur C. Butcher, EVP & Group President at Boston Scientific, reports the acquisition and disposal of common stock and restricted stock units.
NYSE
Executive Vice President of Global Operations at Boston Scientific, John Bradley Sorenson, exercised stock options and sold shares under a pre-established Rule 10b5-1 trading plan.
NYSE
Form 4: Boston Scientific EVP Wendy Carruthers Executes Stock Options and Sells Shares Under 10b5-1 Plan
Wendy Carruthers, EVP of Human Resources at Boston Scientific, exercised stock options and sold shares of common stock on May 1, 2024, under a pre-established Rule 10b5-1 trading plan.
NYSE
Director Edward J. Ludwig of Boston Scientific Corp. exercised stock options and sold shares on April 26, 2024.
NYSE
Form 4: Boston Scientific EVP John Bradley Sorenson Executes Stock Option and Sells Shares Under 10b5-1 Plan
John Bradley Sorenson, EVP of Global Operations at Boston Scientific, exercised stock options and sold shares of common stock under a pre-established Rule 10b5-1 trading plan.
NYSE
Form 4: Boston Scientific EVP Wendy Carruthers Executes Stock Options and Sells Shares Under 10b5-1 Plan
Wendy Carruthers, EVP of Human Resources at Boston Scientific, exercised stock options and sold shares of common stock on April 1, 2024, under a pre-established Rule 10b5-1 trading plan.
NYSE
Executive Vice President of Boston Scientific, Jeffrey B. Mirviss, sold shares of common stock under a pre-established Rule 10b5-1 trading plan.
NYSE
An amended SEC Form 4 reveals a correction to a previous filing regarding the withholding of Boston Scientific common stock for taxes upon the vesting of restricted stock units for executive Eric Francis Yves Thepaut.
NYSE
Emily Woodworth, SVP, Global Controller and CAO of Boston Scientific, reports acquisition of stock options and restricted stock units.
NYSE
Wendy Carruthers, EVP of Human Resources at Boston Scientific, executed stock options and sold shares under a pre-established Rule 10b5-1 trading plan.
NYSE
Arthur Butcher, EVP & Group President at Boston Scientific, reports exercising stock options and selling shares under a pre-established 10b5-1 trading plan.